Products

L-Valine Methyl Ester Hydrochloride

    • Product Name: L-Valine Methyl Ester Hydrochloride
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 704410
    Product Name L-Valine Methyl Ester Hydrochloride
    Iupac Name Methyl (2S)-2-amino-3-methylbutanoate hydrochloride
    Synonyms (S)-2-Amino-3-methylbutyric acid methyl ester hydrochloride
    Cas Number 6306-52-1
    Ec Number 228-612-0
    Mdl Number MFCD00038599
    Molecular Formula C6H14ClNO2
    Molecular Weight 167.63 g/mol
    Exact Mass 167.0713 g/mol
    Appearance White to off-white crystalline powder
    Melting Point 188-190 °C (lit.)
    Optical Rotation [α]20/D = +22° to +25° (c = 2 in water)
    Solubility Soluble in water, methanol, ethanol, DMF, and DMSO
    Purity ≥98% (TLC/GC)
    Storage Conditions Store at 2-8 °C under inert atmosphere, protected from moisture
    Smiles COC(=O)[C@@H](N)C(C)C.Cl

    As an accredited L-Valine Methyl Ester Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packaged as 25 g of L-Valine Methyl Ester Hydrochloride in a sealed amber glass vial under inert atmosphere.
    Container Loading (20′ FCL) One 20′ FCL container loaded with L-Valine Methyl Ester Hydrochloride, properly packed on pallets, secured, and sealed for transport.
    Shipping Ship L-Valine Methyl Ester Hydrochloride in tightly sealed containers, protected from moisture and light. Store at ambient temperature in a cool, dry area. Ensure proper labeling and compliance with local regulations. No special hazard classification required under normal shipping conditions, but avoid contact with skin and eyes.
    Storage Store L-Valine Methyl Ester Hydrochloride in a tightly sealed container away from moisture and direct light. Keep in a cool, dry, well-ventilated area, ideally between 2–8°C for long-term stability. Avoid contact with strong oxidizing agents. Ensure the container is properly labeled and protected from physical damage.
    Shelf Life Shelf life: typically 2 years when stored tightly sealed in a cool, dry place, protected from moisture and light.
    Application of L-Valine Methyl Ester Hydrochloride
    During solution-phase assembly of short-chain peptide active pharmaceutical ingredients, L-valine methyl ester hydrochloride is charged as a carboxyl-protected amino component whose free α-amine participates in amide bond formation after in situ neutralization. The hydrochloride salt is intentionally selected instead of the free amine to reduce aerial oxidation and hygroscopicity during bulk storage; however, the counterion can depress coupling rate if it is not neutralised with a tertiary amine before or during activation. Addition ratios on pilot-scale campaigns typically hold the ester hydrochloride at 1.05–1.20 mol equivalent relative to the activated carboxyl component, while 1.05–1.10 mol equivalent of N-methylmorpholine is introduced to maintain a reaction pH of 8.3–8.7 in dimethylformamide. Higher pH accelerates methyl ester hydrolysis; lower pH stalls nucleophilic attack by the amine. The downstream process commonly uses 1.0 mol eq of the carboxyl species activated by 1.10 mol eq of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1.10 mol eq of hydroxybenzotriazole at 0–5 °C, followed by warming to 18–22 °C for 8–12 h. Production batches in glass-lined reactors of 1000–6000 L with pitched-blade agitation at 90–120 rpm have shown that agitation below 60 rpm prolongs dissolution of the hydrochloride and creates local concentration gradients that reduce coupling conversion. Washing with 5–7% sodium bicarbonate solution removes the liberated hydrochloride salt and residual hydroxybenzotriazole-related impurities before phase separation and vacuum distillation at 40 °C. Final isolated intermediates are crystallised from ethyl acetate/n-heptane and dried in an agitated filter dryer at 45–55 °C to a loss-on-drying value not exceeding 0.5%. Compliance in this segment is governed by ICH Q7 Section 7.3 for raw-material identity and purity verification, with chloride content measured by Ph. Eur. 2.5.35 and residue on ignition per USP 281. Finished product types derived from this route include di-, tri-, and tetrapeptide APIs of 300–900 Da for therapeutic indications where valine is the N-terminal residue or part of a hydrophobic binding motif.

    Why Does the N-Pentanoyl-L-Valine Methyl Ester Step Require Schotten–Baumann pH Control Below 8?

    Manufacture of valsartan-class antihypertensive APIs uses L-valine methyl ester hydrochloride as the chiral pool fragment for the side chain (S)-N-pentanoyl-L-valine. The first unit operation acylates the free amine with valeryl chloride in a two-phase dichloromethane–water system under Schotten–Baumann conditions. Because the methyl ester is susceptible to alkaline hydrolysis and the chiral centre can racemise under excessive base, the aqueous phase is maintained at pH 7.2–7.8 by controlled addition of 20–25% aqueous sodium carbonate. Valeryl chloride is charged at 1.05–1.10 mol eq per mol of L-valine methyl ester hydrochloride, and the exotherm is held below 10 °C in a glass-lined reactor. After phase separation, the organic layer is washed with dilute HCl to remove residual triethylamine or carbonate, dried over anhydrous sodium sulfate, and concentrated under vacuum at 35–40 °C. The resulting N-pentanoyl-L-valine methyl ester is then N-alkylated with 0.98–1.02 mol eq of a biphenyl tetrazole benzyl halide in dimethylformamide using potassium carbonate as base at 55–65 °C for 6–10 h. The process is sensitive to temperature: above 70 °C enantiomeric impurity generation accelerates, while below 50 °C alkylation conversion drops below acceptable limits. Chiral HPLC with a polysaccharide-based stationary phase is applied, and the (S)-enantiomer area percent is controlled at not less than 99.5%. Final saponification of the methyl ester with lithium hydroxide in methanol–water at 0–5 °C yields valsartan acid after acidification and recrystallisation from acetonitrile. Compliance anchors include ICH Q3A for residual solvents, ICH M7 for mutagenic impurities from the biphenyl halide alkylator, and USP 232/233 for elemental impurities.
    Unit operationControl parameterAcceptance rangeReference standard
    AcylationAqueous phase pH7.2–7.8ICH Q7 §7.31
    AcylationValeryl chloride stoichiometry1.05–1.10 mol eqIn-process HPLC
    AlkylationReaction temperature55–65 °CChiral HPLC
    HydrolysisMethyl ester saponification pH11.5–12.0Reaction monitoring
    Final APIEnantiomeric purity99.5% areaUSP 621 chiral method
    Finished products from this process are high-purity valsartan API and its N-pentanoyl-L-valine methyl ester intermediate intended for antihypertensive formulations.

    Sodium Borohydride–Iodine Reduction of the Ester Hydrochloride to (S)-Valinol

    Reduction of L-valine methyl ester hydrochloride to (S)-valinol proceeds via a sodium borohydride–iodine system generated in situ in tetrahydrofuran. The feed ratio is set at 1.5–1.6 mol eq of sodium borohydride and 0.45–0.50 mol eq of iodine per mol of ester hydrochloride. The reduction is exothermic and is monitored by disappearance of the methyl ester carbonyl band at 1740 cm⁻¹ in Fourier-transform infrared analysis. Addition is maintained below 0 °C to prevent over-reduction and volatile by-product formation; after complete conversion, the reaction is quenched with 10% ammonium chloride solution at 0–5 °C and extracted into dichloromethane. Vacuum distillation at 12–15 mmHg and 90–100 °C yields (S)-valinol as a colourless to pale-yellow liquid. The standard for this segment is ISO 9001:2015 Section 8.4 for supplier quality management, supplemented by REACH registration data for methanolic by-products. Terminal products are chiral oxazaborolidines, amino alcohol–metal complexes, and polymer-supported ligands used in catalytic asymmetric reductions of ketones.Cosmetic oligopeptide actives that require a valine residue are produced by stepwise solution-phase or fragment coupling using L-valine methyl ester hydrochloride as the protected amino component. The compound is incorporated at a molar input corresponding to the final peptide sequence position, typically 0.95–1.05 mol eq relative to the growing chain, with dicyclohexylcarbodiimide and hydroxybenzotriazole as coupling reagents in dichloromethane. After removal of the methyl ester protecting group by saponification at 0–5 °C with 1.0 mol L⁻¹ lithium hydroxide, the peptide is isolated by precipitation from methyl tert-butyl ether. The finished cosmetic actives are then formulated into anti-wrinkle serums and peptide creams, where the peptide concentration in the final cosmetic product is usually 1.0–5.0 wt% of the dried peptide powder. Compliance for this segment falls under EC 1223/2009 Annex II for restricted substances and ISO 16128 for natural origin index calculation when the valine component is derived from fermentation. Because the methyl ester hydrochloride is an intermediate and not a cosmetic ingredient itself, residual solvent and peptide impurity limits are set by the cosmetic formulator’s supplier specification, often through USP 467 for residual solvents.

    N-Carboxyanhydride Ring-Opening Polymerization Feedstock for Poly(L-valine) Block Copolymers

    Conversion of L-valine methyl ester hydrochloride to L-valine N-carboxyanhydride proceeds through methyl ester cleavage and subsequent reaction with triphosgene. The hydrochloride removal step uses acetone washing at 0–5 °C to prevent premature anhydride formation. Ring-opening polymerisation is initiated with n-hexylamine at monomer-to-initiator molar ratios of 20:1 to 100:1, which control the degree of polymerisation. Reaction is run in anhydrous dimethylformamide at 25–35 °C under nitrogen for 24–72 h, with monomer conversion followed by the disappearance of the anhydride stretch at 1850 cm⁻¹. The resulting poly(L-valine) block copolymer is precipitated in diethyl ether and vacuum-dried at 30 °C. For biomedical use, ISO 10993-5 cytotoxicity evaluation applies to the polymer; residual tin or boron from catalyst systems must meet ICH Q3D elemental impurity limits when the polymer enters a drug delivery formulation. Terminal products include biodegradable polymeric nanoparticles, amphiphilic micelles, and drug-eluting implant coatings. Published comparative data for this specific polymerisation configuration are limited; the monomer-to-initiator range reflects standard ring-opening polymerisation practice for amino acid N-carboxyanhydrides.Quantitative chiral purity analysis of amine-based APIs depends on derivatizing agents derived from L-valine methyl ester hydrochloride through reaction with substituted dinitrofluorobenzene in acetonitrile. The reagent is added to the amine sample at 1.0–5.0 mol eq in 0.1 mol L⁻¹ sodium bicarbonate buffer at pH 9.0. Derivatization proceeds at 40 °C for 30–60 min, and the resulting diastereomers are separated by reversed-phase HPLC with UV detection at 340 nm. Compliance for this segment is ISO 17025 for testing laboratories and ICH Q2(R1) for analytical method validation. Terminal finished products are chiral derivatizing reagents and certified reference standard kits used in enantiomeric excess determination of amine-based active pharmaceutical ingredients. Published industrial data for this exact hydrochloride derivative in routine multi-ton analytical reagent campaigns are limited; the stated ranges reflect typical batch sheet limits applied by custom synthesis suppliers.
    Free Quote

    Competitive L-Valine Methyl Ester Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    L-Valine methyl ester hydrochloride, CAS 6306-52-1, is the C-terminal methyl ester of L-valine stabilized as the hydrochloride salt. The IUPAC designation is methyl (2S)-2-amino-3-methylbutanoate hydrochloride; the molecular formula is C6H13NO2·HCl and the molecular weight is 167.63 g/mol. Commercial catalog entries assign the product under H-Val-OMe·HCl or L-Valine methyl ester hydrochloride, and the high-purity grade is supplied as a white to off-white crystalline powder. In this form the N-terminal amino group is protonated, which reduces atmospheric CO2 uptake, retards autocondensation, and provides a stoichiometric counterion for controlled neutralization with a tertiary amine before coupling.

    On production-scale peptide coupling trains, the hydrochloride is neutralized in situ with N,N-diisopropylethylamine or N-methylmorpholine in anhydrous N,N-dimethylformamide or dichloromethane at 0–5 °C. The methyl ester blocking group remains stable under acidic activation conditions but is deliberately labile to alkaline hydrolysis. Process workup is therefore maintained below pH 8.5 unless C-terminal deprotection is intended; lithium hydroxide in tetrahydrofuran/water at 0–5 °C is a standard reagent for post-coupling methyl ester removal. In pharmaceutical intermediate manufacture, the compound is used as a valine donor in tetrazole-containing angiotensin II receptor blocker intermediates, where the free amine is coupled to an activated biphenyltetrazole carboxylate under carbodiimide/HOBt activation.

    Specification Limits and Lot Release Parameters for L-Valine Methyl Ester Hydrochloride

    No harmonized pharmacopeial monograph is available for this specific hydrochloride; release therefore follows supplier specifications that combine chromatographic, spectroscopic, and wet-chemical methods. The limits below are representative of commercial pharmaceutical intermediate grades and must be verified against the lot-specific certificate of analysis.

    Representative release parameters for high-purity L-valine methyl ester hydrochloride
    ParameterMethod or standardTypical acceptance limit
    AppearanceVisual inspectionWhite to off-white crystalline powder
    IdentificationIR/ATR spectroscopyMatches reference spectrum
    AssayHPLC, USP <621>≥98.0% on anhydrous basis
    Enantiomeric excessChiral HPLC or derivatization≥99.0%
    Specific rotation [α]D20USP <781>, c = 2 in H2O+15.0° to +17.0°
    Loss on dryingUSP <731>≤0.5%
    Residue on ignitionUSP <281>≤0.1%
    Chloride contentArgentometric titration20.8–21.8%

    Residual solvent testing in pharmaceutical intermediate supply chains is carried out by headspace gas chromatography under USP <467>. Methanol from esterification is typically controlled at ≤3000 ppm, consistent with ICH Q3C Option 2 concentration limits; dichloromethane and other process solvents are controlled to their corresponding ICH Q3C limits. Packaging for 25 kg drum lots is commonly double polyethylene-lined fiber drums under nitrogen. Storage in a dry, well-ventilated area at 15–25 °C is standard, and containers should be closed immediately after use.

    Enantiomeric purity is confirmed on chiral stationary phases because D-valine methyl ester hydrochloride must be controlled to support downstream chiral requirements. LC-MS and HPLC methods are also used to distinguish valine methyl ester from isoleucine methyl ester, which shares the same molecular mass and similar chromatographic retention. Method specificity is demonstrated during qualification to ensure that the isomeric impurity does not co-elute with the main peak.

    Production-scale drying often uses nitrogen-inerted fluid-bed dryers or vacuum tray dryers. Control of residual water is necessary because water introduces stoichiometric uncertainty in peptide coupling and can hydrolyze the methyl ester during storage. Milling to a controlled particle size range of approximately 100–300 μm improves dissolution in DMF and reduces dust-generated moisture pickup; very fine fractions are more hygroscopic and require sealed handling systems. These constraints are observed across amino acid hydrochloride esters on multi-kilogram batches.

    What Conditions Affect Racemization and Hydrolysis During Coupling?

    L-Valine methyl ester hydrochloride functions as the amine nucleophile after neutralization. Since the valine carboxyl is blocked as the methyl ester, the compound does not form an oxazolone during carbodiimide activation in the same manner as N-acylated amino acids; the principal stereochemical risk is therefore not racemization at the valine chiral center but methyl ester hydrolysis during extended aqueous workup or excessive base exposure. For carbodiimide-mediated couplings, the N-protected amino acid should be pre-activated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and HOBt in anhydrous DMF at 0 °C for 5–10 min, followed by addition of the neutralized ester. HATU or HBTU may be substituted when coupling is slow, but residual tetramethylguanidinium by-products must be removed by aqueous washing under pH control.

    Temperature control in jacketed glass reactors should be held within ±2 °C. DIPEA addition above approximately 1.2 equivalents relative to the hydrochloride can elevate local pH and accelerate methyl ester saponification. Strong bases such as sodium hydride, potassium tert-butoxide, or DBU should not be used for neutralization because they deprotonate the α-position and generate elimination or racemization by-products. When the methyl ester must be retained during downstream coupling, aqueous workup pH is kept below 8.0 and extraction is completed within 30 min at 0–10 °C to limit hydrolysis.

    In a representative carbodiimide coupling, N-protected valine is pre-activated with EDC hydrochloride and HOBt in DMF at 0 °C; the hydrochloride salt is neutralized with DIPEA at approximately 2.2 equivalents total base, where 1.0 equivalent liberates the amine and the balance scavenges carbodiimide-derived HCl. Coupling is monitored by HPLC at 214 nm, with process control based on disappearance of the activated ester rather than an isolated yield value. This approach is used in kilogram laboratory and pilot-scale batch processing.

    For couplings involving Fmoc-protected acyl donors, alkaline methyl ester cleavage after coupling is incompatible because Fmoc is removed under the same basic conditions. In such schemes, a benzyl ester or tert-butyl ester is selected for valine C-terminal protection, or the methyl ester is retained and the global deprotection route is designed accordingly.

    Selective C-terminal protection separates L-valine methyl ester hydrochloride from L-valine free amino acid. The free amino acid is zwitterionic and requires aqueous base or high-temperature dissolution for homogeneous coupling, while the methyl ester hydrochloride dissolves readily in DMF, dichloromethane, and methanol. The free amino ester base is a low-melting material with limited storage stability; the hydrochloride salt is crystalline, non-volatile, and yields more reproducible gravimetric charging on production scales.

    When the Methyl Ester Is Selected Over Ethyl, Benzyl, or N-Protected Valine Synthons

    Selection depends on the deprotection sequence and the available hydrogenation or hydrolysis equipment. The methyl ester is the most compact ester protecting group, minimizes steric bulk at the C-terminus, and is removed with mild alkaline saponification. It is, however, more susceptible to hydrolysis than the ethyl or benzyl ester. Ethyl ester hydrochloride has slightly higher lipophilicity and slower alkaline hydrolysis kinetics; benzyl ester hydrochloride permits removal by hydrogenolysis under neutral conditions. N-protected derivatives such as Boc-Val-OMe and Fmoc-Val-OMe are carboxyl-activated acyl donors after deprotection, whereas H-Val-OMe·HCl is the amine component after neutralization. These differences are summarized in the comparative matrix below.

    Comparative handling and deprotection features of valine-derived synthons
    SynthonC-terminal blockN-terminal stateSolubility in aprotic mediaPreferred deprotectionMain handling limitation
    L-Valine methyl ester hydrochlorideMethyl esterHydrochloride saltDMF, DCM, methanolMild alkaline hydrolysis (LiOH)Hygroscopic; protect from moisture
    L-Valine methyl ester free baseMethyl esterFree amineDCM, ethersSameLow storage stability; CO2 absorption; autocondensation
    L-Valine free amino acidFree carboxylZwitterionPoor in DMF/DCMNot applicableInsoluble; requires water/base
    L-Valine ethyl ester hydrochlorideEthyl esterHydrochloride saltDMF, DCM, ethanolAlkaline hydrolysis, slower than methylSimilar hygroscopicity
    L-Valine benzyl ester hydrochlorideBenzyl esterHydrochloride saltDMF, DCMHydrogenolysis (Pd/C, H2)Hydrogenation equipment; catalyst removal

    Published data comparing hydrolysis half-lives of methyl and ethyl esters under identical pH are limited; however, the standard reactivity order under alkaline conditions is methyl > ethyl > benzyl, which is applied as a process selection rule. In multi-step campaigns, methyl ester protection is preferred when late-stage mild hydrolysis is acceptable and when avoiding catalytic hydrogenation equipment reduces protective group complexity.

    Hydrolytic Stability and Storage Boundaries

    The hydrochloride salt is hygroscopic. Equilibrium moisture uptake depends on particle size distribution and ambient relative humidity; process lots that have been exposed to humid air can show surface aggregation and increased water content. For moisture-sensitive peptide couplings, lots are dried in a vacuum tray dryer at 40–50 °C under −0.08 MPa for 4–6 h before use. Drying temperatures above 60 °C are avoided because the salt can form melted or sintered masses near its melting endotherm, and prolonged heating can promote ester decomposition. Differential scanning calorimetry of typical lots shows a sharp melting endotherm near 168–171 °C, but the value may vary with heating rate and residual solvent content.

    The material is incompatible with strong oxidizing agents, strong bases, and acid chlorides under neutralization conditions. Once neutralized in solution, the free amine should be used immediately; standing in open vessels permits CO2 absorption and re-protonation by atmospheric water, which changes the active species concentration and can reduce coupling reproducibility. Aqueous workup of the free ester should be performed with cold buffer systems rather than strongly alkaline brines; pH is maintained below 8.0 to limit methyl ester hydrolysis. Container headspace should be flushed with nitrogen after each withdrawal, and inventory should not be held under active vacuum unless a desiccant trap is installed because low-pressure conditions can accelerate loss of water rather than improve stability.

    Top